wholesale Wegovy Semaglutide Injection – For Laboratory Research Use Only

描述

Semaglutide, the active ingredient in Wegovy, is a GLP-1 receptor agonist researched for its impact on glucose metabolism, appetite regulation, and weight loss mechanisms. This formulation, at 2.27mg/ml in a 3ml pre-filled pen, is specifically manufactured for research applications in metabolic disorders, type 2 diabetes, and obesity studies.

This product is produced by Novo Nordisk (Denmark) and is approved under NMPA Registration No. SJ20240021, with national drug code 86978997003529.

Please note: The product is intended solely for laboratory research purposes and is not approved for clinical or veterinary use.

Wegovy Semaglutide Product Specifications

Wegovy Semaglutide Mechanism of Action & Research Applications

Semaglutide functions as a GLP-1 receptor agonist, mimicking incretin hormones that increase insulin secretion and reduce glucagon levels in a glucose-dependent manner. In preclinical and laboratory research, it has shown promise in models of:

• Obesity and weight control

• Type 2 diabetes mellitus

• Appetite regulation and satiety pathways

• Cardiometabolic and hepatic metabolism

• Combination therapy with other anti-diabetic agents

Wegovy Semaglutide Observed Side Effects in Research Models

• Nausea or gastrointestinal discomfort

• Loss of appetite or anorexia

• Injection site reactions

• Mild hypoglycemia in certain models

• Fatigue or headache

Wegovy Semaglutide Safety & Handling Guidelines

Use Restriction: For laboratory research use only. Not for diagnostic, therapeutic, or veterinary purposes.

Handling: Wear protective gloves and lab coat. Avoid contact with skin or eyes.

Storage: Refrigerate between 2–8°C. Protect from direct light. Do not freeze.

Disposal: Dispose in accordance with local laboratory biohazard protocols.

Research Use Disclaimer

This product is strictly for laboratory research use only. It is not intended for human consumption, diagnosis, or treatment. Misuse is dangerous and may be illegal. Always follow institutional safety protocols.